PATENT CLAIM ANALYSIS

Application Number: 15992989
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "245000"]

Abstract:
The present invention relates to the use of substituted pyrimidine derivatives to modulate tropomyosin-related kinase (Trk) family protein kinase, and the use of the substituted pyrimidine derivatives for the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.

Claim (Index 12):
A compound of  claim 1 , or a pharmaceutically acceptable salt thereof, for use in the treatment of pain, cancer, inflammation, and neurodegenerative diseases.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 93.0
- Lexical Diversity: 1.62
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15285234', '14440817', '14775434', '13377031', '13376814']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7926793014368854
- 35 USC 102 Novelty (BERT): 0.5233454541412235
- Combined Prediction Score: 0.7657459167073192
- Mean Citation Score: 314.521298
- Max Citation Score: 332.7134
- Similarity Product: 254.0906879704476

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test